偉鴻集團控股(03321.HK)擬攜手廣東匯徽隆開展酒生產及銷售等業務
格隆匯 10 月 23日丨偉鴻集團控股(03321.HK)公告,於2020年10月23日,公司與廣東匯徽隆投資有限公司("廣東匯徽隆")訂立框架合作協議("框架合作協議"),根據框架合作協議,雙方擬合作於中華人民共和國安徽省開展酒研發、生產及銷售等綜合業務。
廣東匯徽隆為一家中國成立的有限公司,主要從事酒、飲料和精製茶製造業務。廣東匯徽隆項下於中國安徽省酒製造業務,先後研發多款高、中、低檔酒產品,並建立省級技術研發中心。
廣東匯徽隆將因應中國大健康主題,於現有白酒系列產品基礎上,開發及生產各類新型健康酒。公司透過訂立框架合作協議,倘與滙徽隆投資成功展開合作,董事會認為,將有助集團進一步擴展業務範圍及多方面收入來源,為集團及其整體股東創造最大價值,同時取得更好的社會效益和企業效益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.